Track Ainos Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Ainos Inc. Common Stock AIMD · Stock Open Ainos Inc. Common Stock in new tab

1.30 USD
EPS
-2.49
P/B
3.01
ROE
-196.30
Beta
2.49
Loading chart...
Key Metrics
Earnings dateMay 11, 2026
EPS-2.49
Book Value0.45
Price to Book3.01
Debt/Equity420.62
% Insiders71.351%
Growth
Revenue Growth-0.97%

DCF Valuation

Tweak assumptions to recompute fair value for Ainos Inc. Common Stock (AIMD)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Ainos Inc. Common Stock Logo Ainos Inc. Common Stock Analysis (AIMD)

United States Health Care Official Website Stock

Is Ainos Inc. Common Stock a good investment? Ainos Inc. Common Stock (AIMD) is currently trading at 1.30 USD.

Earnings Schedule: Ainos Inc. Common Stock is expected to release its next earnings report on May 11, 2026.

Investor FAQ

Does Ainos Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Ainos Inc. Common Stock?

Ainos Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be May 11, 2026. The company currently has a trailing EPS of -2.49.

Company Profile

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Exchange Ticker
NMS (United States) AIMD
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Aug. 9, 2022 0.07
Dec. 14, 2023 1:5
June 30, 2025 1:5
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion